NUTEX HEALTH REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE

Rhea-AI Summary

Nutex Health Inc. (NASDAQ: NUTX) has successfully regained compliance with Nasdaq's minimum bid price requirement. This follows the company's 1:10 reverse stock split on July 3, 2024, after which the closing bid price of Nutex Health's common stock remained above $1.00 per share until July 23, 2024. The Nasdaq Stock Market has formally notified Nutex Health of its compliance with Listing Rule 5550(a)(2), considering the previous bid price deficiency matter closed.

Nutex Health operates as a physician-led, technology-enabled integrated healthcare delivery system, comprising 21 state-of-the-art micro hospitals across 9 states and primary care-centric, risk-bearing physician networks. This development ensures the company's continued listing on the Nasdaq Capital Market, as mandated by the Hearing Panel's decision on June 14, 2024.

Positive

• Regained compliance with Nasdaq's minimum bid price requirement
• Continued listing on Nasdaq Capital Market secured
• Successful implementation of 1:10 reverse stock split

Negative

• Required a reverse stock split to meet minimum bid price requirement

Financial Analyst

Nutex Health's regaining of Nasdaq compliance is a significant development for the company and its investors. This news addresses a critical concern that had been hanging over the stock, potentially impacting its marketability and investor confidence.

The successful implementation of the 1:10 reverse stock split on July 3, 2024, was a strategic move that effectively boosted the share price above the $1.00 threshold required by Nasdaq. This maneuver, while reducing the total number of outstanding shares, doesn't fundamentally change the company's market capitalization or underlying value. However, it does have several implications:

• Improved perception: A higher share price often attracts more institutional investors and funds that have minimum price requirements for investments.
• Reduced volatility: Typically, higher-priced stocks are less susceptible to large percentage swings caused by small dollar movements.
• Potential for increased analyst coverage: Stocks trading above $5.00 often receive more attention from Wall Street analysts.

It's important to note that while compliance has been regained, the company's fundamental financial performance and growth prospects remain the key drivers of long-term value. Investors should focus on Nutex Health's operational metrics, revenue growth and profitability in the coming quarters to gauge the company's true health and potential.

The closure of this compliance issue removes a significant overhang from the stock, potentially paving the way for renewed investor interest. However, it's important to remember that maintaining compliance will require sustained trading above the $1.00 mark, which will depend on the company's performance and market conditions going forward.

Legal Expert

The regaining of Nasdaq compliance by Nutex Health is a critical legal and regulatory milestone. This development has several important legal and corporate governance implications:

• Continued Listing: By meeting the minimum bid price requirement, Nutex Health has secured its position on the Nasdaq Capital Market. This is important for maintaining visibility, liquidity and access to capital markets.
• Regulatory Compliance: The company has successfully addressed a significant regulatory challenge, demonstrating its ability to meet and maintain Nasdaq's stringent listing requirements.
• Disclosure Obligations: The timely disclosure of this development through a Current Report on Form 8-K shows the company's commitment to transparency and compliance with SEC reporting requirements.
• Corporate Action Effectiveness: The 1:10 reverse stock split, a significant corporate action, has achieved its intended purpose, showcasing effective corporate governance and decision-making.

While this resolution is positive, investors should be aware that maintaining compliance is an ongoing obligation. The company must continue to meet all Nasdaq listing requirements, including the minimum bid price, to avoid future delisting risks.

From a broader perspective, this compliance achievement may enhance Nutex Health's credibility with investors, partners and regulators. It could potentially facilitate easier access to capital if needed, as being listed on a major exchange like Nasdaq is often a prerequisite for certain types of institutional investment.

However, it's important to note that while the compliance issue is resolved, this does not absolve the company from other ongoing legal and regulatory obligations. Investors should continue to monitor the company's SEC filings and disclosures for a comprehensive understanding of its legal and regulatory standing.

HOUSTON, July 29, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, announced today that it has received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market as required by the Hearing Panel's June 14, 2024 decision, as previously disclosed in the Company's Current Report on Form 8-K filed on June 18, 2024.

The Nasdaq staff made this determination of compliance after the closing bid price of the Company's common stock traded above $1.00 per share from July 3, 2024, the date of the Company's 1:10 reverse stock split, to July 23, 2024. Accordingly, Nasdaq has determined that the Company has regained compliance with Listing Rule 5550(a)(2) and Nasdaq considers the prior bid price deficiency matter now closed.

About Nutex Health Inc.

Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division.

The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 21 facilities in 9 states.

The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). We provide management, administrative and other support services to our affiliated hospitals and physician groups.  Our cloud-based proprietary technology platform aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers, allowing us to deliver greater quality care more efficiently. 

Forward-Looking Statements

Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company.  Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2023 and its Current Report on Form 10-Q for the periods ended March 31, 2024 under the heading "Risk Factors" in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.

View original content:https://www.prnewswire.com/news-releases/nutex-health-regains-compliance-with-nasdaq-minimum-bid-price-302207876.html

SOURCE Nutex Health, Inc.

FAQ

What was the outcome of Nutex Health's (NUTX) compliance review with Nasdaq?

Nutex Health (NUTX) has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market.

When did Nutex Health (NUTX) implement its reverse stock split?

Nutex Health (NUTX) implemented a 1:10 reverse stock split on July 3, 2024.

How long did Nutex Health's (NUTX) stock price need to remain above $1.00 to regain compliance?

Nutex Health's (NUTX) stock closing bid price remained above $1.00 per share from July 3, 2024, to July 23, 2024, satisfying Nasdaq's compliance requirements.

What is the scope of Nutex Health's (NUTX) healthcare operations?

Nutex Health (NUTX) operates 21 state-of-the-art micro hospitals across 9 states and manages primary care-centric, risk-bearing physician networks.